These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4403078)

  • 1. Tyrosine hydroxylation in the rat striatum in vitro and in vivo after nigral lesion and chlorpromazine treatment.
    Fyrö B; Nybäck H; Sedvall G
    Neuropharmacology; 1972 Jul; 11(4):531-7. PubMed ID: 4403078
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of nigral lesion on chlorpromazine-induced acceleration of dopamine synthesis from [14C]tyrosine.
    Nybäck H; Sedvall C
    J Pharm Pharmacol; 1971 May; 23(5):322-6. PubMed ID: 4397399
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of brain lesions and chlorpromazine on accumulation and disappearance of catecholamines formed in vivo from 14 C-tyrosine.
    Nybäck H
    Acta Physiol Scand; 1972 Jan; 84(1):54-64. PubMed ID: 5029384
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemical or electrolytic lesion of the substantia nigra: early effects on neostriatal dopamine metabolism.
    Agid Y; Javoy F; Glowimski J
    Brain Res; 1974 Jul; 74(1):41-9. PubMed ID: 4847602
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of amines in the striatum in monkeys with nigral lesions. The disposition, biosynthesis and metabolites of [3H]dopamine and [14C]serotonin in the striatum.
    Goldstein M; Anagnoste B; Battista AF; Owen WS; Nakatani S
    J Neurochem; 1969 Apr; 16(4):645-53. PubMed ID: 4976670
    [No Abstract]   [Full Text] [Related]  

  • 7. Axoplasmic transport of dopamine in nigro-striatal neurons.
    Fibiger HC; McGeer EG; Atmadja S
    J Neurochem; 1973 Aug; 21(2):373-85. PubMed ID: 4125072
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels.
    Kogan FJ; Nichols WK; Gibb JW
    Eur J Pharmacol; 1976 Apr; 36(2):363-71. PubMed ID: 6286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs affecting monoamines in the basal ganglia.
    Bartholini G; Pletscher A
    Adv Biochem Psychopharmacol; 1972; 6():135-48. PubMed ID: 4560163
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute effects of morphine on dopamine synthesis and release and tyrosine metabolism in the rat striatum.
    Gauchy C; Agid Y; Glowinski J; Cheramy A
    Eur J Pharmacol; 1973 Jun; 22(3):311-9. PubMed ID: 4354579
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum.
    Walters JR; Roth RH
    Biochem Pharmacol; 1972 Aug; 21(15):2111-21. PubMed ID: 4645883
    [No Abstract]   [Full Text] [Related]  

  • 12. Catecholamine synthesis: physiological coupling to precursor supply.
    Milner JD; Wurtman RJ
    Biochem Pharmacol; 1986 Mar; 35(6):875-81. PubMed ID: 2869759
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of intranigral Mn2+ on striatal and nigral synthesis and levels of dopamine and cofactor.
    Daniels AJ; Abarca J
    Neurotoxicol Teratol; 1991; 13(5):483-7. PubMed ID: 1684634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine turnover in the rat corpus striatum: in vivo and in vitro studies on the action of amantadine.
    Vaatstra WJ; Eigeman L
    Eur J Pharmacol; 1974 Feb; 25(2):185-90. PubMed ID: 4435022
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
    Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
    Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat.
    Agid Y; Javoy F; Glowinski J
    Nat New Biol; 1973 Oct; 245(144):150-1. PubMed ID: 4517903
    [No Abstract]   [Full Text] [Related]  

  • 17. Formation of catecholamines from phenylalanine in brain--effects of chlorpromazine and catron.
    Bagchi SP; Zarycki EP
    Biochem Pharmacol; 1973 Jun; 22(11):1353-68. PubMed ID: 4146983
    [No Abstract]   [Full Text] [Related]  

  • 18. Feedback control of dopamine synthesis in dopaminergic terminals of the rat striatum.
    Javoy F; Agid Y; Bouvet D; Glowinski J
    J Pharmacol Exp Ther; 1972 Sep; 182(3):454-63. PubMed ID: 4403433
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of some psychotropic drugs on tyrosine hydroxylase activity in different structures of the rat brain.
    Besson MJ; Cheramy A; Gauchy C; Musacchio J
    Eur J Pharmacol; 1973 May; 22(2):181-6. PubMed ID: 4146008
    [No Abstract]   [Full Text] [Related]  

  • 20. Uptake, localization and release of taurine in the rat basal ganglia.
    Della Corte L; Clarke DJ; Bolam JP; Smith AD
    Adv Exp Med Biol; 1987; 217():285-94. PubMed ID: 3434424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.